A Phase IV, Non-Inferiority, Observer blind, Randomized Clinical Study Comparing Safety and Immunogenicity of DTP-HB-HIB Vaccination by Disposable-Syringe Jet Injector to Vaccination by Needle and Syringe in Healthy Infants in India.

Trial Profile

A Phase IV, Non-Inferiority, Observer blind, Randomized Clinical Study Comparing Safety and Immunogenicity of DTP-HB-HIB Vaccination by Disposable-Syringe Jet Injector to Vaccination by Needle and Syringe in Healthy Infants in India.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 04 May 2017

At a glance

  • Drugs Hib-DTP-hepatitis B vaccine (Primary)
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
  • Focus Pharmacodynamics
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 10 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.
    • 10 Nov 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 08 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top